InterCure Ltd (INCR) – Business Wire
-
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
-
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint
-
Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies
-
International Cannabis Brand Cookies and InterCure Announce European Expansion
Back to INCR Stock Lookup